FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology, namely to the strain A/17/Texas/2012/30 (H3N2) of influenza virus. The given viral strain is deposited in the State Collection of Viruses of FGBU (Federal State Budgetary Institution) D.I. Ivanovskiy Scientific Research Institute of Virology of the Ministry of Health of Russia, under No. 2737.
EFFECT: presented invention enables producing the new strain A/17/Texas/2012/30 (H3N2) of influenza virus, which is used to produce the intranasal live influenza vaccine for adults and children.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2011/89 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2012 |
|
RU2532844C2 |
STRAIN OF INFLUENZA VIRUS A/17/INDIANA/11/72 (H3N2v) FOR PRODUCTION OF LIQUID INFLUENZA INTRANASAL VACCINE FOR ADULTS AND FOR CHILDREN | 2013 |
|
RU2545706C1 |
VACCINE INFLUENZA VIRUS STRAIN A/17/HONGKONG/2014/8296 (H3N2) FOR PREPARING LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2016 |
|
RU2606019C1 |
REASSORTANT VACCINE STRAIN OF INFLUENZA VIRUS A/17/TASMANIA/2020/151 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND FOR CHILDREN | 2023 |
|
RU2825672C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/HONG KONG/2019/2573 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783894C1 |
REASSORTANT VACCINE STRAIN OF INFLUENZA A/17/DARWIN/2021/410 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825673C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/SOUTH AUSTRALIA/2019/122 (H3N2) FOR PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783877C1 |
VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/3610 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2734897C1 |
VACCINE STRAIN OF INFLUENZA A/17/KANSAS/2017/631 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2732610C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2019/276 (H1N1) PDM09 FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783878C1 |
Authors
Dates
2015-09-20—Published
2013-11-05—Filed